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Abstract
Background Vitamin D deficiency is a common finding in
obese subjects even before any bariatric operation. How-
ever, most previous studies reporting on high rates of
vitamin D deficiency in obese subjects have not systemat-
ically controlled for seasonal variations. Furthermore, the
existence of seasonal variation in serum 25-hydroxyvitamin
D3 levels has not been well documented in obese subjects
so far.
Methods Serum 25-hydroxyvitamin D3 levels were mea-
sured in 248 obese subjects (body mass index: range, 30.1–
68.9 kg/m2). Fat mass was determined using standard
bioelectrical impedance analysis.
Results Serum 25-hydroxyvitamin D3 levels decreased with
the increasing body mass index and fat mass (both P<
0.001) and showed a marked variation across the seasons of
the year (P<0.001), which was not affected by the degree
of obesity. According to the variation in absolute levels, the
prevalence of vitamin D deficiency (<50 nmol/l) was 3.8-
fold higher during winter than during summer (91.2% vs.
24.3%; P<0.001).
Conclusion Data show a marked seasonal variation in
absolute serum 25-hydroxyvitamin D3 concentrations and
prevalence of vitamin D deficiency in subjects with mild to
extreme obesity. Considering the increasing number of
studies reporting on vitamin D deficiency in obesity, the
present finding points to season as a crucial factor that
should not be neglected when assessing serum levels of this
vitamin in obese subjects.
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Introduction
Vitamin D deficiency is increasingly recognized as an
important risk factor for many diseases such as diabetes,
hypertension, cardiovascular diseases, and several types of
cancer [1]. A large number of studies have reported on
distinctly reduced circulating 25-hydroxyvitamin D3 levels
in obese subjects which may contribute to the health-
impairing effects of obesity [2–12]. Low 25-hydroxyvitamin
D3 concentrations in obesity have been attributed to an
increased storage of this lipid-soluble vitamin in adipose
tissue [13, 14] and an overall reduced exposure of the skin to
sunlight due to limited mobility and potentially embarrass-
ment [6]. While the capacity of the skin to produce vitamin
D during sunlight exposure appears to be unaffected, the
increase in serum 25-hydroxyvitamin D3 levels after a
standardized UV-B radiation is reduced by 52% in obese as
compared to lean subjects [13]. This finding again points to
an enhanced storage of the vitamin in subcutaneous fat in
obese subjects.
Considering the prominent role of sunlight in the skin’s
generation of vitamin D, it is not surprising that serum 25-
hydroxyvitamin D3 levels have consistently been found to
show a marked seasonal variation [14–17]. Importantly,
most previous studies reporting on high rates of vitamin D
deficiency in obese subjects [5–8, 18] have not systemat-
ically controlled for such seasonal variations. Furthermore,
the existence of seasonal variation in serum 25-hydroxyvi-
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tamin D3 levels has not been well documented in obese
subjects so far [8]. A previous study revealed a weaker
seasonal variation in overweight [body mass index (BMI)>
25 kg/m2] as compared to lean (BMI<25 kg/m2) subjects
[19]. Also, two previous studies investigating serum 25-
hydroxyvitamin D3 levels in extremely obese subjects (BMI
>40 kg/m2) did not find any differences in levels obtained
during the winter as compared to the summer season [12,
20]. However, results of these studies should be interpreted
with caution since in both studies, a rather low number of
subjects was tested (n=73 and n=41, respectively).
In this study, we assessed serum 25-hydroxyvitamin D3
levels in a sample of 248 subjects with a wide range of
obesity. Based on the proposed mechanisms of vitamin D
deficiency in obesity, i.e., an increased storage in adipose
tissue and a rare exposure to sunlight, we hypothesized that
the seasonal variation in 25-hydroxyvitamin D3 levels
diminishes with increasing degrees of obesity.
Methods
Serum 25-hydroxyvitamin D3 levels were measured in 248
(176 women/72 men) obese subjects (BMI>30 kg/m2) who
attended our Interdisciplinary Obesity Center between
November 2005 and January 2008. Patients who were
taking vitamin D supplements or had undergone a bariatric
operation prior to the present assessment were excluded
from the study. Also, patients with overt renal function
impairment (serum creatinine concentration>120 μmol/l for
men, >100 μmol/l for women) were excluded from the
study. Written informed consent was obtained from all
patients.
Height and weight were measured with patients wearing
light clothing and no shoes. BMI was defined as weight
(kg) divided by height squared (m2). Fat mass (FM) was
determined using standard bioelectrical impedance analysis
(BIA 101, AKERN Bioresearch, Florence, Italy). Blood
samples were drawn in the morning (0800–1100 hours)
after an overnight fast, and serum 25-hydroxyvitamin D3
levels were determined by high-performance liquid chro-
matography (Chromsystems, Instruments & Chemicals
GmbH, Munich, Germany). A serum 25-hydroxyvitamin
D3 level <75 nmol/l was defined as vitamin D insufficiency,
a serum level <50 nmol/l as deficiency, and a serum level
<25 nmol/l as severe deficiency [1].
Data were analyzed by using SPSS 12.1 for Windows
(SPSS Inc., Chicago, IL, USA). Unless otherwise indicated,
data are reported as mean±SD. To analyze serum 25-
hydroxyvitamin D3 levels according to different degrees of
Fig. 1 Seasonal variation in serum 25-hydroxyvitamin D3 within three different BMI groups and tertiles of fat mass (FM)
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obesity, the study population was divided into three BMI
groups: 30–40 kg/m2, 40–50 kg/m2, and >50 kg/m2. Also,
the study population was divided into tertiles according to
their FM: tertile 1—FM ≤50 kg, tertile 2—FM 50–62 kg,
tertile 3—FM >62 kg. For analysis of seasonal variations,
we subdivided the year into six 2-month periods: February–
March, April–May, June–July, August–September, October–
November, December–January. These periods roughly
approximate the seasonal changes in availability of sunlight
in Switzerland (latitude of 47°,27′,0″ N; Federal Office of
Meteorology and Climatology MeteoSwiss). Variables were
compared between different seasons by analysis of variance
(ANOVA) for continuous variables and χ2 test for discrete
variables. To adjust for potential confounders, e.g., sex, age,
and indices of adiposity (BMI, FM), these variables were
included as covariates in respective analysis of covariance
models. Pearson’s correlation coefficient and partial correla-
tion analysis were used to assess relationships between
variables. A P value <0.05 was considered significant.
Results
The study population was characterized by a mean age of 41±
12 years (range, 17–72 years) and a mean BMI of 44.1±
6.7 kg/m2 (range, 30.1–68.9 kg/m2). In agreement with the
wide BMI range, subjects also showed a wide range of FM
(22.8–102.0 kg; mean±SD, 57±15 kg). BMI values as well
as FM values were equally distributed across the six different
2-month intervals (P=0.284 and P=0.208, respectively).
Serum concentration of 25-hydroxyvitamin D3 ranged
from 5 to 142 nmol/l (mean±SD, 48±25 nmol/l). BMI was
inversely correlated with serum 25-hydroxyvitamin D3
concentrations (r=−0.151; P=0.017), and this correlation
remained significant after adjusting for age and sex (r=
−0.148; P=0.020). Also, FM showed an inverse correlation
with serum 25-hydroxyvitamin D3 levels (r=−0.150; P=
0.018), and again, this correlation remained significant after
adjusting for age and sex (r=−0.158; P=0.013).
Overall, serum 25-hydroxyvitamin D3 levels showed a
marked variation across the seasons of the year (P<0.001),
with highest levels during summer (August–September,
69.5±28.3 nmol/l) and lowest levels during winter period
(February–March, 28.9±15.7 nmol/l). Adjustment for sex,
age, and indices of adiposity did not affect the significance
of seasonal variation (all P<0.001). Also, none of these
variables showed a significant interaction with the effects of
the season on serum 25-hydroxyvitamin D3 levels (all P>
0.15). Regardless of the seasonal variation, ANOVA
indicated a significant decrease in levels with increasing
BMI and FM (both P<0.001).
Separate analyses of different BMI groups and FM
tertiles revealed similar results with a significant variation
across seasons in all groups (all P<0.004) except for the
highest BMI group (>50 kg/m2) in which, most likely due
to small sample size (n=41), the effect of season did not
reach significance (P=0.078; Fig. 1).
According to the seasonal variation in absolute levels, there
was also a clear-cut variation in the prevalence of vitamin D
insufficiency, deficiency and, severe deficiency (all P<0.001;
Fig. 2). For instance, the deficiency rate was 3.8-fold higher
in February–March than in August–September (91.2% vs.
24.3%; P<0.001).
Fig. 2 Seasonal variation in the prevalence of serum 25-hydroxyvitamin
D3 insufficiency (<75 nmol/l), deficiency (<50 nmol/l), and severe
deficiency (<25 nmol/l)
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Discussion
Present data for the first time show a marked seasonal
variation in serum 25-hydroxyvitamin D3 levels in subjects
with a wide range of obesity, a finding that has previously
been well documented in study populations with a much
lower averaged BMI [14–17]. Although serum 25-
hydroxyvitamin D3 levels clearly decreased with increasing
BMI and FM, these variables did not affect the seasonal
variation in circulating levels of the vitamin. Thus, our data
do not support the hypothesis that the putatively reduced
exposure to sunlight or the increased storage capacity in
adipose tissue diminishes the seasonal variation in vitamin
D levels in obese subjects.
The present finding of a marked seasonal variation of
serum 25-hydroxyvitamin D3 levels and deficiency in obese
subjects sheds new light on the previously reported high
rates of vitamin D deficiency in obesity [5–8, 18]. While
most of the previous studies have not controlled for the
season of the year at which the vitamin D levels were
measured, our data point to a 3.8-fold higher vitamin D
deficiency rate in the winter than summer period. Thus, the
impact of season on circulating vitamin D concentrations
should be considered when reporting on prevalence rates of
vitamin D deficiency in obese subjects regardless of being
in a pre- or postoperative bariatric state. Finally, present
results may also yield clinical implications by showing an
extremely high rate of vitamin D deficiency in obese
subjects during the winter season (91.2% in February–
March). It remains to be established whether obese subjects
benefit from vitamin D supplementation especially during
this time of the year.
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